Longest follow up trial of Merck\'s Keytruda sets new standard for five year survival in lung cancer httpbit.ly2WFhUNLÂ lungcancer oncology pharmapic.twitter.comB9rPJAcAX1
Longest follow up trial of Merck's #Keytruda sets new standard for five year survival in lung cancer http://bit.ly/2WFhUNL #lungcancer #oncology #pharmapic.twitter.com/B9rPJAcAX1
More From BioPortfolio on "Longest follow up trial of Merck's #Keytruda sets new standard for five year survival in lung cancer http://bit.ly/2WFhUNL #lungcancer #oncology #pharmapic.twitter.com/B9rPJAcAX1"